Table 4 Pharmacological treatment given to patients
From: Abnormal glucose regulation in Chinese patients with coronary artery disease: a gender analysis
Type | Male | Female | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
DM (n = 636) | NDM (n = 83) | IGR (n = 283) | Normal (n = 338) | Total (n = 1340) | DM (n = 317) | NDM (n = 41) | IGR (n = 105) | Normal (n = 109) | Total (n = 572) | |
β-Blocker | 520 (82) | 61 (74) | 233 (82) | 276 (82) | 1090 (81) | 225 (71) | 29 (71) | 85 (81) | 85 (78) | 424 (74) |
ACEI/ARB | 553 (87) | 70 (84) | 254 (90) | 290 (86) | 1167 (87) | 251 (79) | 32 (78) | 88 (84) | 86 (79) | 457 (80) |
Diuretics | 153 (24) | 18 (22) | 55 (19) | 40 (12) | 266 (20) | 109 (34) | 6 (15) | 12 (11) | 17 (16) | 144 (25) |
Statins | 563 (89) | 75 (90) | 252 (89) | 312 (92) | 1202 (90) | 267 (84) | 38 (93) | 92 (88) | 90 (87) | 493 (86) |
CCB | 345 (54) | 45 (54) | 154 (54) | 177 (52) | 721 (54) | 190 (60) | 26 (63) | 77 (73) | 54 (50) | 347 (61) |
Nitrates | 422 (66) | 63 (76) | 207 (73) | 247 (73) | 439 (70) | 238 (75) | 31 (76) | 64 (61) | 74 (68) | 407 (71) |
Aspirin | 613 (96) | 82 (99) | 276 (98) | 334 (99) | 1305 (97) | 282 (89) | 41 (100) | 96 (91) | 107 (98) | 526 (92) |
Clopidogrel | 538 (85) | 80 (96) | 254 (90) | 317 (94) | 1189 (89) | 254 (80) | 35 (85) | 85 (81) | 89 (82) | 463 (81) |
DM drugs | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Oral agents | 364 (67) | Â | Â | Â | Â | 170 (53) | Â | Â | Â | Â |
Insulin | 147 (23) | Â | Â | Â | Â | 73 (23) | Â | Â | Â | Â |
Combined | 77 (12) | Â | Â | Â | Â | 40 (13) | Â | Â | Â | Â |
No drugs/ Diet | 48 (8) | Â | Â | Â | Â | 34 (11) | Â | Â | Â | Â |